Novo Nordisk's data exclusivity on semaglutide expired January 4, 2026 , and the key Canadian patent has lapsed
KH: Investigation, Writing original draft, Writing review & editing, Formal analysis, Validation
A study published in the Journal of Pharmacy Technology compared oral and injectable semaglutide and found no significant differences in weight loss or blood sugar control after 26 weeks
Now I wear shorts without thinking twice
How Wolverine Blend Works BPC157 mechanisms May enhance fibroblast activity, collagen synthesis, and angiogenesis, supporting faster repair of muscle, tendon, ligament, nerve, and gut tissue in animal models
Risks of all-cause and suicide mortality in mental disorders: a meta-review